New Developments in Retinal Pharmacotherapy

Beyond Biologics: Is Immunomodulation the New Wave?

Beyond Biologics: Is Immunomodulation the New Wave?

Vascular leakage, angiogenesis and inflammation are all properties of VEGF…

Expiration Date: 8/27/2014

Max Credits: 0

View Activity

Immunosuppression 101 for the Retinal Specialist

Immunosuppression 101 for the Retinal Specialist

Immunosuppression indicated as steroid-sparing agent for patients with uve…

Expiration Date: 8/20/2014

Max Credits: 0

View Activity

Long-term Outcomes with Ocriplasmin

Long-term Outcomes with Ocriplasmin

I am going to talk about ocriplasmin’s clinical trial, specifically phase …

Expiration Date: 7/31/2014

Max Credits: 0

View Activity

Patient Perceptions of the Treatment Regimen and Expected Outcomes with Intravitreal anti-VEGF Injections for Wet Age-Related Macular Degeneration

Patient Perceptions of the Treatment Regimen and Expected Outcomes with Intravitreal anti-VEGF Injections for Wet Age-Related Macular Degeneration

anti-VEGF for wet AMD for both patient and doctors have raised expectation…

Expiration Date: 7/28/2014

Max Credits: 0

View Activity

Emerging Approaches to the Management of Symptomatic Vitreomacular Adhesion and Macular Hole

Emerging Approaches to the Management of Symptomatic Vitreomacular Adhesion and Macular Hole

What should be happening in this is normal separation of the vitreous from…

Expiration Date: 7/24/2014

Max Credits: 0

View Activity

Aflibercept Update 2013

Aflibercept Update 2013

The key feature here is the dissociation constant..…

Expiration Date: 7/21/2014

Max Credits: 0

View Activity

Can anti-VEGF Therapy Cause Glaucoma?

Can anti-VEGF Therapy Cause Glaucoma?

I think everyone is well aware that when you inject anti-VEGF..…

Expiration Date: 6/26/2014

Max Credits: 0

View Activity

Bevacizumab, Ranibizumab, and Stroke

Bevacizumab, Ranibizumab, and Stroke

If there's an increase of 1% rate of cardiovascular risks..…

Expiration Date: 6/19/2014

Max Credits: 0

View Activity

Ocriplasmin in Clinical Practice: How and When to Use It

Ocriplasmin in Clinical Practice: How and When to Use It

We have a new class of drug, a new pharmaceutical, a new type of indicatio…

Expiration Date: 6/11/2014

Max Credits: 0

View Activity

Vitreolysis: Rationale and Clinical Trials

Vitreolysis: Rationale and Clinical Trials

There are two broad categories of vitreolytic agents..…

Expiration Date: 6/10/2014

Max Credits: 0

View Activity